Quantcast

Latest Gram positive bacteria Stories

2014-08-28 08:27:37

-- Fujifilm's pAVEway(TM) Platform Demonstrated >25-fold Improvement in SYN-004 Expression Titers -- ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced today confirmation of exceptional results from the initial phase of cGMP manufacturing of...

2014-08-27 16:24:34

LONDON, Aug. 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholdershttps://www.reportbuyer.com/product/2242717/Botulinum-Neurotoxins-A-comparative-industry-analysis-of-products-pipelines-technologies-and-stakeholders.htmlBotulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholdersThis business...

2014-08-26 08:30:16

ROCKVILLE, Md., Aug. 26, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile), will be presented at the Infectious Disease Week (IDWeek 2014(TM)) held by...

2014-08-25 12:26:44

OTTAWA, Aug. 25, 2014 /CNW/ - Issue Home canning is a popular and safe way to preserve food for later use. Jams, pickles, soups, sauces, meat and seafood are frequently canned in glass jars. If home canned foods are not properly prepared, they can cause serious illness such as botulism. Botulism is caused by the toxin of bacterium - called Clostridium botulinum -that affects the nervous system and can cause paralysis. It is estimated there are approximately 4 million cases...

2014-08-22 12:25:38

Control allows users to monitor assay performance with confidence MILFORD, Mass., Aug. 22, 2014 /PRNewswire/ -- SeraCare Life Sciences, a provider of high-quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced the launch of its new ACCURUN(®) 501 C. difficile Control - the company's first molecular control product targeting hospital acquired infections....

2014-08-19 08:29:22

-- Two of Company's Anti-Infective Programs to be Presented at Highly Regarded Scientific Conference: Pertussis and C. difficile -- ROCKVILLE, Md., Aug. 19, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that its novel C. difficile development program will be highlighted at the 54(th) Interscience...

2014-08-06 12:29:16

St. Jude Children's Research Hospital discovery lays the groundwork for a new class of antibiotics to fight multi-drug resistant Staphylococcus aureus and related bacteria that cause serious infections. MEMPHIS, Tenn., Aug. 6, 2014 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital scientists have discovered an enzyme that regulates production of the toxins that contribute to potentially life-threatening Staphylococcus aureus infections. The study recently appeared in...

2014-08-05 08:32:23

-- Executed Agreement with Evonik for Formulation Development, Analytical Services andClinical Drug Manufacturing -- ROCKVILLE, Md., Aug. 5, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, today announced that, with a new multi-service agreement in place, the Company is on track to initiate Phase Ia and Ib clinical trials of...

2014-07-29 12:36:03

ROCKVILLE, Md., July 29, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that in view of the unusual market activity in the Company's stock, the NYSE MKT (the "Exchange") has contacted the Company in accordance with its usual practice. The Company stated that its policy is not to comment on unusual market activity....

2014-07-16 08:29:22

SER-109 demonstrated remarkably high clinical cure rate and excellent safety profile CAMBRIDGE, Mass., July 16, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel treatments for diseases related to the human microbiome, today announced that it has completed enrollment for its single-arm, open-label clinical trial of SER-109, its first-in-field, oral microbiome therapeutic designed for the treatment of recurrent Clostridium difficile Infection...


Latest Gram positive bacteria Reference Libraries

0_acc42e71b0d88e5b1f3520ddbf139579
2011-04-28 14:45:47

Streptococcus salivarius is a species of spherical, Gram-positive bacteria which colonize the mouth and upper respiratory tract of humans a few hours after birth, making further exposure to the bacteria harmless. The bacterium is an opportunistic pathogen which rarely makes its way into the bloodstream where it is associated with septicemia cases in people with neutropenia. It has different characteristics when exposed to different environmental nutrients. In the lab a SYTA plate is used...

0_1b337eb3ae50456f130e22153cc80436
2011-04-28 14:40:22

Streptococcus pyogenes is a spherical, Gram-positive bacterium is the cause of Group A streptococcal infections. It displays streptococcal group A antigen on its cell wall. When it is cultured on blood agar plates it produces large zones of beta-hemolysis. They are catalase-negative and in ideal conditions it has an incubation period of about 1-3 days. It is an infrequent part of the skin flora. It is the cause of many important human diseases, ranging from mild superficial skin infections...

0_9fb0173be70876d98667eddc1e274866
2011-04-28 14:27:08

Streptococcus pneumoniae, or pneumococcus, is Gram-positive, alpha-hemolytic, bile-soluble aerotolerant, anaerobic member of the genus Streptococcus. It was recognized as a major cause of pneumonia in the late 19th century and is thus the subject of many humoral immunity studies. It causes many other types of pneumococcal infections other than pneumonia including acute sinusitis, otitis media, meningitis, bacteremia, sepsis, septic arthritis, peritonitis, cellulites, and brain abscess. It...

0_097d9a33e1035f1ca4b33243c5beaafa
2011-04-26 23:26:27

Streptococcus oralis is a Gram positive bacterium that grows characteristically in chains. On a Wilkins-Chalgren agar plate it will form slam white colonies. It is classified as a member of the streptococcus mitis group and is found in high numbers in the oral cavity. S. oralis produce neuraminidase and an IgA protease and cannot bind α-amylase.

0_b8b1f3bc239d54bf277f330c7dafdbb1
2011-04-26 23:21:38

Streptococcus mutans is a Gram-positive cocci, Facultative anaerobic bacterium commonly found in the human oral cavity and is a significant contributor to tooth decay. J Kilian Clarke first described the microbe in 1924. The first colonizers of the tooth surface are mainly Neisseria spp. and streptococci, including S. mutans. The pioneer species changes the local environmental conditions through growth and metabolism thus allowing more fastidious organisms to further colonize after them,...

More Articles (14 articles) »
Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related